Telecommunication Industry Analysis, Telecommunication Market, Telecom Industry, Market Reports, Industry Analysis, Trends, Analysis, Overview, Statistics - PowerPoint PPT Presentation

About This Presentation
Title:

Telecommunication Industry Analysis, Telecommunication Market, Telecom Industry, Market Reports, Industry Analysis, Trends, Analysis, Overview, Statistics

Description:

The Generic Drugs market in Japan can be divided into three segments: Generic Prescription Medicines, Super Generics, and Biosimilars. This report covers the present scenario and the growth prospects of the Generic Drugs market in Japan for the period 2015–2019. – PowerPoint PPT presentation

Number of Views:583

less

Transcript and Presenter's Notes

Title: Telecommunication Industry Analysis, Telecommunication Market, Telecom Industry, Market Reports, Industry Analysis, Trends, Analysis, Overview, Statistics


1
 Generic Drugs Market in Japan 2015-2019
2
Summary
A generic drug is a duplicate of brand-name drugs
and has the same dosage form, active
ingredient(s), potency, route of administration,
quality, and intended use as that of branded
drugs. Generic drugs enter the market once the
patent protection of the original developer
expires. Generally, the cost of generic drugs is
50-70 percent lower than that of their brand-name
counterparts, while meeting the very same
standards of safety, quality, and efficacy as the
innovator drugs. Generic drugs help the
manufacturer by eliminating the need to develop
and market a new drug. As the patent approaches
expiration, manufacturers can apply to the FDA
for approval to manufacture and sell generic
versions of the drug. Generic drugs are equal to
and within the bioequivalence range of branded
drugs. This report analysts forecast the Generic
Drugs market in Japan to grow at a CAGR of 8.16
percent over the period 2014-2019 .
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
3
Covered in this ReportThe Generic Drugs market
in Japan can be divided into three segments
Generic Prescription Medicines, Super Generics,
and Biosimilars. This report covers the present
scenario and the growth prospects of the Generic
Drugs market in Japan for the period 20152019.
To calculate the market size, the report
considers the revenue generated from the
following segments Generic Prescription
Medicines Super Generics BiosimilarsThe
Generic Drugs market in Japan 2015-2019, has been
prepared based on an in-depth market analysis
with inputs from industry experts. The report
covers the market landscape of the Generic Drugs
market in Japan and its growth prospects over the
coming years. The report also includes a
discussion of the key vendors operating in this
market.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
4
Key Vendors Meiji Seika Pharma Nichi-Iko
Pharmaceutical Nipro Pharma Sawai
Pharmaceuticals Teva Pharmaceutical
Industries Towa PharmaceuticalOther Prominent
Vendors Actavis Daiichi Sankyo Daito
Pharmaceutical Eisai Fuji Pharma
GlaxoSmithKline
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
5
Hikari Pharmaceutical Hospira Mylan Nihon
Generic Nippon Chemipher Nippon Kayaku
Nissin Pharmaceutical Ohara Pharmaceutical
Pfizer Sandoz Taiyo Yakuhin Takeda
Pharmaceutical Zensei Pharmaceutical Industries
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
6
Market Driver Increase in Number of Patent
Expiries For a full, detailed list, view our
report.Market Challenge Intense Competition
among Vendors For a full, detailed list, view
our reportMarket Trend Increase in MA For
a full, detailed list, view our report
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
7
Key Questions Answered in this Report What will
the market size be in 2019 and what will the
growth rate be? What are the key market
trends? What is driving this market? What are
the challenges to market growth? Who are the
key vendors in this market space? What are the
market opportunities and threats faced by the key
vendors? What are the strengths and weaknesses
of the key vendors?
W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
8
Table of Contents
  1. Executive Summary
  2. List of Abbreviations
  3. Scope of the Report
  4. Market Research Methodology
  5. Introduction
  6. Country Overview of Japan
  7. Approval Pathway of Generic Drugs in Japan
  8. Market Landscape
  9. Market Segmentation by Product Category
  10. Market Segmentation by Therapeutic Application

W www.bharatbook.com , T  91 22 27810772,
27810773, E  info_at_bharatbook.com
9
To view the full Executive Summary and Table of
Contents, please visit  Generic Drugs Market
in Japan 2015-2019 Contact Us-Call India
91-22-27810772/73Email id info_at_bharatbook.com
Website www.bharatbook.com Our Blog
https//www.bharatbook.com/blog/
Follow Us On
Write a Comment
User Comments (0)
About PowerShow.com